Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367–416.
Google Scholar
Wetzstein N, Hügel C, Wichelhaus TA, Hogardt M, Eickmeier O, Küpper-Tetzel CP, et al. Species distribution and clinical features of infection and colonisation with non-tuberculous mycobacteria in a tertiary care centre, central germany, 2006–2016. Infection. 2019;47:817–25.
Google Scholar
Lin C, Russell C, Soll B, Chow D, Bamrah S, Brostrom R, et al. Increasing prevalence of nontuberculous mycobacteria in respiratory specimens from US-Affiliated Pacific Island Jurisdictions(1). Emerg Infect Dis. 2018;24:485–91.
Google Scholar
Pang Y, Tan Y, Chen J, Li Y, Zheng H, Song Y, et al. Diversity of nontuberculous mycobacteria in Eastern and Southern china: a cross-sectional study. Eur Respir J. 2017;49:1601429.
Park SC, Kang MJ, Han CH, Lee SM, Kim CJ, Lee JM, et al. Prevalence, incidence, and mortality of nontuberculous mycobacterial infection in korea: a nationwide population-based study. BMC Pulm Med. 2019;19:140.
Google Scholar
Ratnatunga CN, Lutzky VP, Kupz A, Doolan DL, Reid DW, Field M, et al. The rise of Non-Tuberculosis mycobacterial lung disease. Front Immunol. 2020;11:303.
Google Scholar
Xu J, Li P, Zheng S, Shu W, Pang Y. Prevalence and risk factors of pulmonary nontuberculous mycobacterial infections in the Zhejiang Province of China. Epidemiol Infect. 2019;147:e269.
Google Scholar
Cândido PH, Nunes Lde S, Marques EA, Folescu TW, Coelho FS, de Moura VC, et al. Multidrug-resistant nontuberculous mycobacteria isolated from cystic fibrosis patients. J Clin Microbiol. 2014;52:2990–7.
Google Scholar
Eisenberg I, Yasin A, Fuks L, Stein N, Saliba W, Kramer MR, et al. Radiologic characteristics of Non-tuberculous mycobacteria infection in patients with bronchiectasis. Lung. 2020;198:715–22.
Google Scholar
Fayos M, Silva JT, López-Medrano F, Aguado JM. Non-Tuberculous mycobacteria and Aspergillus lung Co-Infection: systematic review. J Clin Med. 2022;11:5619.
Alemayehu A, Kebede A, Neway S, Tesfaye E, Zerihun B, Getu M, et al. A glimpse into the genotype and clinical importance of Non tuberculous mycobacteria among pulmonary tuberculosis patients: the case of Ethiopia. PLoS ONE. 2022;17:e0275159.
Google Scholar
De Keukeleire S, Mathys V, Van den Wijngaert S, Van De Vyvere M, Jonckheere S, De Beenhouwer H, et al. Nontuberculous mycobacteria among pulmonary tuberculosis patients: a retrospective Belgian multicenter study. Acta Clin Belg. 2017;72:45–8.
Google Scholar
Huang CT, Tsai YJ, Shu CC, Lei YC, Wang JY, Yu CJ, et al. Clinical significance of isolation of nontuberculous mycobacteria in pulmonary tuberculosis patients. Respir Med. 2009;103:1484–91.
Google Scholar
Jun HJ, Jeon K, Um SW, Kwon OJ, Lee NY, Koh WJ. Nontuberculous mycobacteria isolated during the treatment of pulmonary tuberculosis. Respir Med. 2009;103:1936–40.
Google Scholar
Zmak L, Obrovac M, Jankovic Makek M, Sabol I, Katalinic-Jankovic V. Isolation of non-tuberculous mycobacteria among tuberculosis patients during a 5-year period in Croatia. Infect Dis (London England). 2015;47:275–6.
Kumar K, Abubakar I. Clinical implications of the global multidrug-resistant tuberculosis epidemic. Clin Med. 2016;16:565–70.
Daley CL, Iaccarino JM, Lange C, Cambau E, Wallace RJ Jr., Andrejak C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. Eur Respir J. 2020;56:2000535.
Turenne CY, Tschetter L, Wolfe J, Kabani A. Necessity of quality-controlled 16S rRNA gene sequence databases: identifying nontuberculous Mycobacterium species. J Clin Microbiol. 2001;39:3637–48.
Google Scholar
Ringuet H, Akoua-Koffi C, Honore S, Varnerot A, Vincent V, Berche P, et al. hsp65 sequencing for identification of rapidly growing mycobacteria. J Clin Microbiol. 1999;37:852–7.
Google Scholar
Zhu L, Jiang G, Wang S, Wang C, Li Q, Yu H, et al. Biochip system for rapid and accurate identification of mycobacterial species from isolates and sputum. J Clin Microbiol. 2010;48:3654–60.
Google Scholar
Gao J, Pei Y, Yan X, Shi G, Li T, Gao M, et al. Emergence of nontuberculous mycobacteria infections during bedaquiline-containing regimens in multidrug-resistant tuberculosis patients. Int J Infect Diseases: IJID: Official Publication Int Soc Infect Dis. 2020;100:196–8.
Google Scholar
Meghji J, Lesosky M, Joekes E, Banda P, Rylance J, Gordon S, et al. Patient outcomes associated with post-tuberculosis lung damage in malawi: a prospective cohort study. Thorax. 2020;75:269–78.
Google Scholar
Sonnenberg P, Murray J, Glynn JR, Thomas RG, Godfrey-Faussett P, Shearer S. Risk factors for pulmonary disease due to culture-positive M. tuberculosis or nontuberculous mycobacteria in South African gold miners. Eur Respir J. 2000;15:291–6.
Google Scholar
Huang M, Tan Y, Zhang X, Wang Y, Su B, Xue Z, et al. Effect of mixed infections with Mycobacterium tuberculosis and nontuberculous mycobacteria on diagnosis of Multidrug-Resistant tuberculosis: A retrospective multicentre study in China. Infect Drug Resist. 2022;15:157–66.
Google Scholar
Duan H, Han X, Wang Q, Wang J, Wang J, Chu N, et al. Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in a Chinese tuberculosis tertiary care center. Sci Rep. 2016;6:36299.
Google Scholar
Wu J, Zhang Y, Li J, Lin S, Wang L, Jiang Y, et al. Increase in nontuberculous mycobacteria isolated in shanghai, china: results from a population-based study. PLoS ONE. 2014;9:e109736.
Google Scholar
Kwak N, Lee CH, Lee HJ, Kang YA, Lee JH, Han SK, et al. Non-tuberculous mycobacterial lung disease: diagnosis based on computed tomography of the chest. Eur Radiol. 2016;26:4449–56.
Google Scholar
Maiga M, Siddiqui S, Diallo S, Diarra B, Traoré B, Shea YR, et al. Failure to recognize nontuberculous mycobacteria leads to misdiagnosis of chronic pulmonary tuberculosis. PLoS ONE. 2012;7:e36902.
Google Scholar
Rodriguez Díaz JC, López M, Ruiz M, Royo G. In vitro activity of new fluoroquinolones and linezolid against non-tuberculous mycobacteria. Int J Antimicrob Agents. 2003;21:585–8.
Google Scholar
Hatakeyama S, Ohama Y, Okazaki M, Nukui Y, Moriya K. Antimicrobial susceptibility testing of rapidly growing mycobacteria isolated in Japan. BMC Infect Dis. 2017;17:197.
Google Scholar
Li G, Pang H, Guo Q, Huang M, Tan Y, Li C, et al. Antimicrobial susceptibility and MIC distribution of 41 drugs against clinical isolates from China and reference strains of nontuberculous mycobacteria. Int J Antimicrob Agents. 2017;49:364–74.
Google Scholar